-
Gen9 and SynbiCITE Announce Partnership to Accelerate Technology Commercialization through Synthetic Biology
Gen9 synthetic DNA to fuel innovations by SynbiCITE community
-
Advanced Electrophoresis Solutions Signs an Exclusive Distributor Partner for Europe
Cambridge, Canada, 10th February 2016 / Sciad Newswire / AES (Advanced Electrophoresis Solutions Ltd.), a pioneer in designing and manufacturing the most reliable, high performance, and high throughput CEInfinite whole column imaging detection capillary isoelectric focusing (iCIEF) systems, proprietary cartridges, ampholytes, and pI standards for the life science industry, is pleased to announce Isogen Life Science B.V. as the exclusive distributor…
-
SynBioBeta is Connecting the Global Synthetic Biology Industry at their 4th Annual London Conference
SynBioBeta returns to Imperial College London.
-
University of Leicester scientist wins Domainex’s STAR Award to support her search for a treatment for non-Hodgkin lymphomas
Domainex Ltd is pleased to announce that the recipient of its latest Discovery STAR Award is Dr Aude Echalier.
-
New study looks at the impact of Boards on Biotech company performance
UK companies performing less well than those in mainland Europe
-
Domainex and Cresset Announce Drug Discovery Services Alliance
Domainex Ltd. and Cresset Discovery Services, today announced an alliance to provide their customers with world-class laboratory-based and computational drug discovery services
-
New Automated SPR Levels the Playing Field in Protein Science
OpenSPR-XT will accelerate discoveries in protein science by offering affordable & fully automated binding kinetics for life sciences researchers from academia to industry.
-
BÜHLMANN Laboratories Opens North American Affiliate
BÜHLMANN Laboratories is proud to announce the availability of its products directly from its new North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire.
-
Leading Healthcare and Life Science Executives Support UK Report Analysing the Realities of Investment in the Sector
With contributions from Rt. Hon. George Freeman MP, Neil Woodford, Imperial Innovations, The London Stock Exchange, BIA and EY, plus case studies on 5 of the UK’s leading success stories, the report illustrates the fundamental truths about investing in the UK.
-
Synpromics and Cell Therapy Catapult Collaborate to Develop Novel Large Scale Viral Vector Manufacturing Platform Based on Stable Producer Cell Lines
Synpromics Ltd and The Cell Therapy Catapult annouce collaboration to reduce cost and increase scale and efficiency of viral vector manufacturing.